BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25553513)

  • 21. Interactions between residues in the oncomodulin CD domain influence Ca2+ ion-binding affinity.
    Treviño CL; Boschi JM; Henzl MT
    J Biol Chem; 1991 Jun; 266(17):11301-8. PubMed ID: 2040635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interconversion of the CD and EF sites in oncomodulin. Influence on the Eu3+ 7F0-->5D0 excitation spectrum.
    Kauffman JF; Hapak RC; Henzl MT
    Biochemistry; 1995 Jan; 34(3):991-1000. PubMed ID: 7827057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the D94S/G98E variant of rat alpha-parvalbumin. An explanation for the reduced divalent ion affinity.
    Tanner JJ; Agah S; Lee YH; Henzl MT
    Biochemistry; 2005 Aug; 44(33):10966-76. PubMed ID: 16101280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of a fifth carboxylate ligand heightens the affinity of the oncomodulin CD and EF sites for Ca2+.
    Henzl MT; Hapak RC; Goodpasture EA
    Biochemistry; 1996 May; 35(18):5856-69. PubMed ID: 8639547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15N nuclear magnetic resonance relaxation studies on rat beta-parvalbumin and the pentacarboxylate variants, S55D and G98D.
    Henzl MT; Wycoff WG; Larson JD; Likos JJ
    Protein Sci; 2002 Jan; 11(1):158-73. PubMed ID: 11742132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1H NMR spectroscopic studies of calcium-binding proteins. 3. Solution conformations of rat apo-alpha-parvalbumin and metal-bound rat alpha-parvalbumin.
    Williams TC; Corson DC; Oikawa K; McCubbin WD; Kay CM; Sykes BD
    Biochemistry; 1986 Apr; 25(7):1835-46. PubMed ID: 3707914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In search for globally disordered apo-parvalbumins: Case of parvalbumin β-1 from coho salmon.
    Vologzhannikova AA; Khorn PA; Kazakov AS; Ismailov RG; Sokolov AS; Uversky VN; Permyakov EA; Permyakov SE
    Cell Calcium; 2017 Nov; 67():53-64. PubMed ID: 29029791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 15N NMR relaxation studies of calcium-loaded parvalbumin show tight dynamics compared to those of other EF-hand proteins.
    Baldellon C; Alattia JR; Strub MP; Pauls T; Berchtold MW; Cavé A; Padilla A
    Biochemistry; 1998 Jul; 37(28):9964-75. PubMed ID: 9665701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-specific replacement of amino acid residues within the CD binding loop of rat oncomodulin.
    Palmisano WA; Treviño CL; Henzl MT
    J Biol Chem; 1990 Aug; 265(24):14450-6. PubMed ID: 2387865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of oncomodulin refined at 1.85 A resolution. An example of extensive molecular aggregation via Ca2+.
    Ahmed FR; Przybylska M; Rose DR; Birnbaum GI; Pippy ME; MacManus JP
    J Mol Biol; 1990 Nov; 216(1):127-40. PubMed ID: 2231727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of monovalent cation identity on parvalbumin divalent ion-binding properties.
    Henzl MT; Larson JD; Agah S
    Biochemistry; 2004 Mar; 43(10):2747-63. PubMed ID: 15005610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solution structure of human beta-parvalbumin and structural comparison with its paralog alpha-parvalbumin and with their rat orthologs.
    Babini E; Bertini I; Capozzi F; Del Bianco C; Hollender D; Kiss T; Luchinat C; Quattrone A
    Biochemistry; 2004 Dec; 43(51):16076-85. PubMed ID: 15610002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating site-specific effects of the -X glutamate in a parvalbumin CD site model peptide.
    Franchini PL; Reid RE
    Arch Biochem Biophys; 1999 Dec; 372(1):80-8. PubMed ID: 10562419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removing the invariant salt bridge of parvalbumin increases flexibility in the AB-loop structure.
    Hoh F; Cavé A; Strub MP; Banères JL; Padilla A
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):733-43. PubMed ID: 19622856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of terbium (III) luminescence enhancement in mutants of EF hand calcium binding proteins.
    Hogue CW; MacManus JP; Banville D; Szabo AG
    J Biol Chem; 1992 Jul; 267(19):13340-7. PubMed ID: 1618836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of parvalbumin and polcalcin divalent ion binding by isothermal titration calorimetry.
    Henzl MT
    Methods Enzymol; 2009; 455():259-97. PubMed ID: 19289210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refined crystal structure of rat parvalbumin, a mammalian alpha-lineage parvalbumin, at 2.0 A resolution.
    McPhalen CA; Sielecki AR; Santarsiero BD; James MN
    J Mol Biol; 1994 Jan; 235(2):718-32. PubMed ID: 8289291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational stabilities of the rat alpha- and beta-parvalbumins.
    Henzl MT; Graham JS
    FEBS Lett; 1999 Jan; 442(2-3):241-5. PubMed ID: 9929009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific substitution of glutamate for aspartate at position 59 of rat oncomodulin.
    Hapak RC; Lammers PJ; Palmisano WA; Birnbaum ER; Henzl MT
    J Biol Chem; 1989 Nov; 264(31):18751-60. PubMed ID: 2572594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of monovalent cations on rat alpha- and beta-parvalbumin stabilities.
    Henzl MT; Larson JD; Agah S
    Biochemistry; 2000 May; 39(19):5859-67. PubMed ID: 10801337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.